{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:36:14Z","timestamp":1759970174117,"version":"build-2065373602"},"reference-count":177,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDC"],"abstract":"<jats:p>The Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A) held its 32nd annual conference in August 2024 at the University of Coimbra, Portugal. There were 8 keynote presentations, 12 early career researcher oral presentations, and 34 poster presentations. Four awards were delivered, two for the best oral communications and two for the best poster presentations.<\/jats:p>","DOI":"10.3390\/ddc4010002","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:17:08Z","timestamp":1736399828000},"page":"2","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["32nd Annual GP2A Medicinal Chemistry Conference"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-8911","authenticated-orcid":false,"given":"Jean-Jacques","family":"H\u00e9lesbeux","sequence":"first","affiliation":[{"name":"Universit\u00e9 Angers, SONAS, SFR QUASAV, F-49000 Angers, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-1638","authenticated-orcid":false,"given":"Florence O.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"School of Chemistry and Analytical Biological Chemistry Research Facility (ABCRF), University College Cork, Western Road, T12K8AF Cork, Ireland"}]},{"given":"Maria Manuel","family":"Silva","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Coimbra, P\u00f3lo das Ci\u00eancias da Sa\u00fade, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal"},{"name":"Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-531 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3895-9631","authenticated-orcid":false,"given":"Alcino J.","family":"Leit\u00e3o","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Coimbra, P\u00f3lo das Ci\u00eancias da Sa\u00fade, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal"},{"name":"Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-531 Coimbra, Portugal"}]},{"given":"Anthony","family":"Burke","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Coimbra, P\u00f3lo das Ci\u00eancias da Sa\u00fade, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal"},{"name":"Coimbra Chemistry Centre, Institute of Molecular Sciences, Chemistry Department, Faculty of Science and Technology, University of Coimbra, 3004-535 Coimbra, Portugal"}]},{"given":"Jorge A. R.","family":"Salvador","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Coimbra, P\u00f3lo das Ci\u00eancias da Sa\u00fade, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal"},{"name":"Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-531 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-9852","authenticated-orcid":false,"given":"Rui","family":"Moreira","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-4672","authenticated-orcid":false,"given":"Em\u00edlia","family":"Sousa","sequence":"additional","affiliation":[{"name":"Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental, Universidade do Porto, Av. General Norton de Matos, s\/n, 4450-208 Matosinhos, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-5035","authenticated-orcid":false,"given":"V\u00e2nia M.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Coimbra, P\u00f3lo das Ci\u00eancias da Sa\u00fade, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal"},{"name":"Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-531 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-8642","authenticated-orcid":false,"given":"Pascal","family":"Marchand","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, Cibles et M\u00e9dicaments des Infections et de l\u2019Immunit\u00e9, IICiMed, UR 1155, F-44000 Nantes, France"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1039\/D2MD00087C","article-title":"Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer\u2019s disease mouse model","volume":"13","author":"Spatz","year":"2022","journal-title":"RSC Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/acs.jmedchem.3c00541","article-title":"Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist\/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer\u2019s Disease Mouse Model","volume":"66","author":"Spatz","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer\u2019s Disease Mouse Model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1021\/jacs.1c13492","article-title":"Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer\u2019s Disease Mouse Model upon Irradiation","volume":"144","author":"Scheiner","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e202306176","DOI":"10.1002\/anie.202306176","article-title":"Visible-Light Photoswitchable Benzimidazole Azo-Arenes as \u03b2-Arrestin2-Biased Selective Cannabinoid 2 Receptor Agonists","volume":"62","author":"Fender","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1039\/D3SC05246J","article-title":"Arylazobenzimidazoles: Versatile visible-light photoswitches with tuneable Z-isomer stability","volume":"15","author":"Odaybat","year":"2024","journal-title":"Chem. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e202411438","DOI":"10.1002\/anie.202411438","article-title":"Photo-BQCA: Positive Allosteric Modulators Enabling Optical Control of the M1 Receptor","volume":"63","author":"Gerwe","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_8","unstructured":"(2024, August 28). Vector-Borne and Parasitic Diseases EURO. Available online: https:\/\/www.who.int\/europe\/health-topics\/vector-borne-diseases."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41893-024-01374-y","article-title":"The urgent need for designing greener drugs","volume":"7","author":"Brodin","year":"2024","journal-title":"Nat. Sustain."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1021\/acsinfecdis.4c00131","article-title":"Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection","volume":"10","author":"Ilbeigi","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/acsinfecdis.4c00185","article-title":"Deciphering Host\u2013Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance","volume":"10","author":"Tagliazucchi","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_12","unstructured":"(2024, August 28). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"ref_13","unstructured":"(2024, August 28). Global Action for Fungal Infections. Available online: https:\/\/gaffi.org."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1039\/C9CS00556K","article-title":"A comprehensive overview of the medicinal chemistry of antifungal drugs: Perspectives and promise","volume":"49","author":"Howard","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: A reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41570-022-00391-9","article-title":"Evaluation guidelines for machine learning tools in the chemical sciences","volume":"6","author":"Bender","year":"2022","journal-title":"Nat. Rev. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10378","DOI":"10.1039\/D3SC03367H","article-title":"The rise of automated curiosity-driven discoveries in chemistry","volume":"14","author":"Bustillo","year":"2023","journal-title":"Chem. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/acscentsci.6b00367","article-title":"Low Data Drug Discovery with One-Shot Learning","volume":"3","author":"Ramsundar","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41586-021-03213-y","article-title":"Bayesian reaction optimization as a tool for chemical synthesis","volume":"590","author":"Shields","year":"2021","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.xcrp.2020.100247","article-title":"Adaptive Optimization of Chemical Reactions with Minimal Experimental Information","volume":"1","author":"Reker","year":"2020","journal-title":"Cell Rep. Phys. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1021\/acs.joc.1c01038","article-title":"Augmenting Adaptive Machine Learning with Kinetic Modeling for Reaction Optimization","volume":"86","author":"Loureiro","year":"2021","journal-title":"J. Org. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100573","DOI":"10.1016\/j.xcrp.2021.100573","article-title":"Combating small-molecule aggregation with machine learning","volume":"2","author":"Lee","year":"2021","journal-title":"Cell Rep. Phys. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41565-024-01673-7","article-title":"A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research","volume":"19","author":"Mendes","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd.2018.116","article-title":"Expanding the medicinal chemistry synthetic toolbox","volume":"17","author":"Bostrom","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41557-018-0021-z","article-title":"Organic synthesis provides opportunities to transform drug discovery","volume":"10","author":"Blakemore","year":"2018","journal-title":"Nat. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1021\/acs.jmedchem.9b01956","article-title":"The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology","volume":"63","author":"Gioiello","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1021\/jm300689c","article-title":"Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases","volume":"55","author":"Butini","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1021\/acschemneuro.1c00192","article-title":"Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents","volume":"12","author":"Grillo","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111674","DOI":"10.1016\/j.ejmech.2019.111674","article-title":"Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems","volume":"183","author":"Grillo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/cmdc.201800397","article-title":"Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain","volume":"13","author":"Brindisi","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"64651","DOI":"10.1039\/C6RA12524G","article-title":"Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: Definition of the structural determinants for enzyme inhibition","volume":"6","author":"Brindisi","year":"2016","journal-title":"RSC Adv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114952","DOI":"10.1016\/j.ejmech.2022.114952","article-title":"Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions","volume":"246","author":"Papa","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1021\/acs.jmedchem.3c01278","article-title":"Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization","volume":"67","author":"Butini","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2300410","DOI":"10.1002\/ardp.202300410","article-title":"Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents","volume":"356","author":"Papa","year":"2023","journal-title":"Arch. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bouz\u00f3n-Arn\u00e1iz, I., Avalos-Padilla, Y., Biosca, A., Ca\u00f1o-Prades, O., Rom\u00e1n-\u00c1lamo, L., Valle, J., Andreu, D., Moita, D., Prud\u00eancio, M., and Arce, E.M. (2022). The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures. BMC Biol., 20.","DOI":"10.1186\/s12915-022-01374-4"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e01127-23","DOI":"10.1128\/aac.01127-23","article-title":"Effect of the aggregated protein dye YAT2150 on Leishmania parasite viability","volume":"68","author":"Iglesias","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10409238.2018.1442408","article-title":"Protein Kinase C: Perfectly Balanced","volume":"53","author":"Newton","year":"2018","journal-title":"Crit. Rev. Biochem. Mol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1021\/jm900229p","article-title":"Design, Synthesis, and Biological Activity of Isophthalic Acid Derivatives Targeted to the C1 Domain of Protein Kinase C","volume":"52","author":"Talman","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/molpharm.120.000094","article-title":"Distinct Regulation of Cardiac Fibroblast Proliferation and Transdifferentiation by Classical and Novel Protein Kinase C Isoforms: Possible Implications for New Antifibrotic Therapies","volume":"99","author":"Karhu","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.phrs.2013.04.008","article-title":"The C1 Domain-Targeted Isophthalate Derivative HMI-1b11 Promotes Neurite Outgrowth and GAP-43 Expression Through PKC\u03b1 Activation in SH-SY5Y cells","volume":"73","author":"Talman","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/acs.jmedchem.2c01448","article-title":"Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted Agonists","volume":"66","author":"Lautala","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1021\/cr300481j","article-title":"C1 Domains: Structure and Ligand-Binding Properties","volume":"114","author":"Das","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cmdc.202000325","article-title":"Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism","volume":"15","author":"Saccoliti","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1039\/C2CS35314H","article-title":"Metal N -Heterocyclic Carbene Complexes as Potential Antitumor Metallodrugs","volume":"42","author":"Liu","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00726-019-02731-4","article-title":"Structure-Guided Approach to Identify a Novel Class of Anti-leishmaniasis Diaryl Sulfide Compounds Targeting the Trypanothione Metabolism","volume":"52","author":"Colotti","year":"2020","journal-title":"Amino Acids"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Battista, T., Colotti, G., Ilari, A., and Fiorillo, A. (2020). Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases. Molecules, 25.","DOI":"10.3390\/molecules25081924"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","article-title":"Inhibition of Leishmania infantum Trypanothione Reductase by Diaryl Sulfide Derivatives","volume":"32","author":"Saccoliti","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"De Lima Cavalcanti, T.Y.V., Pereira, M.R., De Paula, S.O., and Franca, R.F.O. (2022). A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses, 14.","DOI":"10.3390\/v14050969"},{"key":"ref_49","unstructured":"World Health Organization (WHO) (2024, August 28). COVID-19 Epidemiological Update. Available online: https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-15-march-2024."},{"key":"ref_50","unstructured":"(2024, August 28). Fragmenstein. Available online: https:\/\/github.com\/matteoferla\/Fragmenstein."},{"key":"ref_51","unstructured":"(2024, August 28). Fragalysis. Available online: http:\/\/cimfr.csircentral.net\/7\/."},{"key":"ref_52","unstructured":"(2024, August 28). The Story So Far. Available online: https:\/\/github.com\/StructuralGenomicsConsortium\/CNP25-CHIKV-nsP3-Macrodomain\/wiki\/The-Story-So-Far."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1038\/ncomms11445","article-title":"Caloric Restriction Blocks Neuropathology and Motor Deficits in Machado-Joseph Disease Mouse Models through SIRT1 Pathway","volume":"7","author":"Carmona","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s40520-022-02257-y","article-title":"SIRT1 Activation and its Circadian Clock Control: A Promising Approach against (Frailty in) Neurodegenerative Disorders","volume":"34","author":"Ribeiro","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.24787","article-title":"Bcl-XL and MCL-1 Constitute Pertinent Targets in Ovarian Carcinoma and Their Concomitant Inhibition is Sufficient to Induce Apoptosis","volume":"126","author":"Brotin","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"103395","DOI":"10.1016\/j.drudis.2022.103395","article-title":"PROTAC Technology: A New Drug Design for Chemical Biology with Many Challenges in Drug Discovery","volume":"28","author":"Guedeney","year":"2023","journal-title":"Drug Discov. Today"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/17460441.2024.2306845","article-title":"Molecular Glue Degraders: Exciting Opportunities for Novel Drug Discovery","volume":"19","author":"Lemaitre","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/jm500672y","article-title":"First Evidence That Oligopyridines, A-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies","volume":"58","author":"Gloaguen","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Alabi, S.B., and Crews, C.M. (2021). Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100647"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yao, T., Xiao, H., Wang, H., and Xu, X. (2022). Recent Advances in PROTACs for Drug Targeted Protein Research. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810328"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/acscentsci.1c00070","article-title":"Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression","volume":"7","author":"Conde","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acschembio.3c00725","article-title":"Machine Learning Uncovers Natural Product Modulators of the 5-Lipoxygenase Pathway and Facilitates the Elucidation of Their Biological Mechanisms","volume":"19","author":"Mikutis","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s42256-022-00581-6","article-title":"Simple Nearest-Neighbour Analysis Meets the Accuracy of Compound Potency Predictions Using Complex Machine Learning Models","volume":"4","author":"Janela","year":"2022","journal-title":"Nat. Mach. Intell."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"26078","DOI":"10.1007\/s11356-021-18404-3","article-title":"Anti-Barnacle Biofouling Coatings for the Protection of Marine Vessels: Synthesis and Progress","volume":"29","author":"Sarkar","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Gomez-Banderas, J. (2022). Marine Natural Products: A Promising Source of Environmentally Friendly Antifouling Agents for the Maritime Industries. Front. Mar. Sci., 9.","DOI":"10.3389\/fmars.2022.858757"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Pereira, D., Pinto, M., Almeida, J.R., Correia-da-Silva, M., and Cidade, H. (2024). The Role of Natural and Synthetic Flavonoids in the Prevention of Marine Biofouling. Mar. Drugs, 22.","DOI":"10.3390\/md22020077"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.scitotenv.2018.06.169","article-title":"Potential of Synthetic Chalcone Derivatives to Prevent Marine Biofouling","volume":"643","author":"Almeida","year":"2018","journal-title":"Sci. Total Environ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1021\/acschemneuro.0c00078","article-title":"An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 Receptors","volume":"11","author":"Jiang","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_70","first-page":"1203","article-title":"Prostaglandin EP2 Receptor: Novel Therapeutic Target for Human Cancers","volume":"42","author":"Sun","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-0716-1221-7_17","article-title":"Luciferase Complementation Approaches to Measure GPCR Signalling Kinetics and Bias","volume":"2268","author":"Dijon","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e22576","DOI":"10.1096\/fj.202201024R","article-title":"Development of Fluorescent Peptide G Protein-Coupled Receptor Activation Biosensors for NanoBRET Characterization of Intracellular Allosteric Modulators","volume":"36","author":"Farmer","year":"2022","journal-title":"FASEB J."},{"key":"ref_73","first-page":"19304","article-title":"4-anilinoquinazoline derivatives as the first potent NOD1-RIPK2 signaling pathway inhibitors at the nanomolar range with potential anti-inflammatory activity","volume":"67","author":"Barczyk","year":"2024","journal-title":"ChemRxiv"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17407","DOI":"10.1021\/acs.jmedchem.4c01313","article-title":"New Potent RIPK2 Inhibitors as a Promising Therapeutic Avenue for Colitis Through the Blockade of NOD Inflammatory Pathways","volume":"67","author":"Rivoal","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.09.031","article-title":"5-Ene-4-thiazolidinones\u2014An efficient tool in medicinal chemistry","volume":"140","author":"Kaminskyy","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2019.04.052","article-title":"Thiazolidinone\/thiazole based hybrids\u2014New class of antitrypanosomal agents","volume":"174","author":"Kryshchyshyn","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Haidar, S., Marminon, C., Aichele, D., Nacereddine, A., Zeinyeh, W., Bouzina, A., Berredjem, M., Ettouati, L., Bouaziz, Z., and Le Borgne, M. (2020). QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor. Molecules, 25.","DOI":"10.3390\/molecules25010097"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1055\/s-0028-1087983","article-title":"Partially Saturated Indeno[1,2-b]indole Derivatives via Deoxygenation of Heterocyclic \u03b1-Hydroxy-N,O-hemiaminals","volume":"2009","author":"Hemmerling","year":"2009","journal-title":"Synthesis"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/jm500943z","article-title":"Converting Potent Indeno[1,2-b]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2","volume":"58","author":"Bouaziz","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Jost, P.J., and Vucic, D. (2020). Regulation of Cell Death and Immunity by XIAP. Cold Spring Harb. Perspect. Biol., 12.","DOI":"10.1101\/cshperspect.a036426"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molcel.2018.01.016","article-title":"Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling","volume":"69","author":"Goncharov","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_82","first-page":"101","article-title":"Anti-mycobacterial activity of labdane and halimane diterpenes obtained from Plectranthus ornatus Codd","volume":"15","author":"Andrade","year":"2018","journal-title":"J. Biomed. Biopharm. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/np020203w","article-title":"Neoclerodane and labdane diterpenoids from Plectranthus ornatus","volume":"65","author":"Rijo","year":"2022","journal-title":"J. Nat. Prod."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2015.09.002","article-title":"Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines","volume":"103","author":"Marchand","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Silvestre, A., Shintre, S.S., and Rachidi, N. (2022). Released Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.825458"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"112956","DOI":"10.1016\/j.ejmech.2020.112956","article-title":"In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition","volume":"210","author":"Bazin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Martins, M.S., Almeida, I.F., Cruz, M.T., and Sousa, E. (2023). Chronic pruritus: From pathophysiology to drug design. Biochem. Pharmacol., 212.","DOI":"10.1016\/j.bcp.2023.115568"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/ja00183a043","article-title":"Studies on the molybdenum cofactor. An unequivocal total synthesis of (.+-.)-urothione","volume":"111","author":"Taylor","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"ref_89","unstructured":"Guerin, D.J., Bair, K.W., Caravella, J.A., Ioannidis, S., Lancia, D.R., Li, H., Mischke, S., Ng, P.Y., Richard, D., and Sciller, S.E.R. (2021). Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors. (No. 10,889,592), U.S. Patent."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Rodrigues, J., Calhelha, R.C., Nogueira, A., Ferreira, I.C.F.R., Barros, L., and Queiroz, M.-J.R.P. (2021). Synthesis of Novel Methyl 7-[(Hetero)arylamino]thieno[2,3-b]pyrazine-6-carboxylates and Antitumor Activity Evaluation: Effects in Human Tumor Cells Growth, Cell Cycle Analysis, Apoptosis and Toxicity in Non-Tumor Cells. Molecules, 26.","DOI":"10.3390\/molecules26164823"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/eve.12672","article-title":"Equine viral arteritis: A respiratory and reproductive disease of significant economic importance to the equine industry","volume":"30","author":"Balasuriya","year":"2018","journal-title":"Equine Vet. Educ."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Valle-Casuso, J.C., Gaudaire, D., Martin-Faivre, L., Madeline, A., Dallemagne, P., Pronost, S., Munier-Lehmann, H., Zientara, S., Vidalain, P.O., and Hans, A. (2020). Replication of Equine arteritis virus is efficiently suppressed by purine and pyrimidine biosynthesis inhibitors. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-66944-4"},{"key":"ref_93","first-page":"ajvr.23.06.0132","article-title":"Equine bronchial epithelial cells are susceptible to cell entry with a SARS-CoV-2 pseudovirus but reveal low replication efficiency","volume":"84","author":"Legere","year":"2023","journal-title":"Am. J. Vet. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: Mechanisms, structures and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1039\/D2BM01237E","article-title":"Chemical modification of proteins\u2013challenges and trends at the start of the 2020s","volume":"11","author":"Fischer","year":"2023","journal-title":"Biomater. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cmdc.202000522","article-title":"Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer","volume":"16","author":"Barcherini","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Barcherini, V., Loureiro, J.B., Sena, A., Madeira, C., Leandro, A.P., Saraiva, L., Antunes, A.M.M., and Santos, M.M.M. (2023). Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators. Pharmaceuticals, 16.","DOI":"10.3390\/ph16020146"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1055\/s-0034-1378829","article-title":"Synthesis of 2,3-Unsaturated Alkynyl O-Glucosides from Tri-O-acetyl-D-glucal by Using Montmorillonite K-10\/Iron(III) Chloride Hexahydrate with Subsequent Copper(I)-Catalyzed 1,3-Dipolar Cycloaddition","volume":"47","author":"Melo","year":"2015","journal-title":"Synthesis"},{"key":"ref_100","unstructured":"(2020). Schr\u00f6dinger Release 2020-1: Desmond Molecular Dynamics System, D.E.S.R., Schr\u00f6dinger. Maestro-Desmond Interoperability Tools."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Barnich, N., Rodrigues, M., Sauvanet, P., Chevarin, C., Denis, S., Le Goff, O., Faure-Imbert, D., Hanh, T., Roques, C.F., and Chassaing, B. (2021). Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094336"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5539\/jfr.v1n2p217","article-title":"Natural Mineral Waters Enhance the Intestinal Health and Stimulate Anti-inflammatory Immune Response in Functional Cell Model of a Non-cancerogenic Human Gut","volume":"1","author":"Trapecar","year":"2012","journal-title":"J. Food Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. ImmunoTher. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/jm1008659","article-title":"Discovery of phosphoric acid mono-{2-[(E\/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): A phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist","volume":"54","author":"Sams","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ja.2008.103","article-title":"Unnarmicins A and C, New Antibacterial Depsipeptides Produced by Marine Bacterium Photobacterium sp. MBIC06485","volume":"61","author":"Oku","year":"2008","journal-title":"J. Antibiot."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.bbrc.2007.10.110","article-title":"Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium","volume":"364","author":"Tanabe","year":"2007","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ribeiro, R., Pinto, E., Fernandes, C., and Sousa, E. (2022). Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies. Mar. Drugs, 20.","DOI":"10.3390\/md20060397"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Costa, L., Sousa, E., and Fernandes, C. (2023). Cyclic Peptides in Pipeline: What Future for These Great Molecules?. Pharmaceuticals, 16.","DOI":"10.3390\/ph16070996"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"106614","DOI":"10.1016\/j.ejps.2023.106614","article-title":"Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development","volume":"192","author":"Puhlmann","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2174\/1570179416666190719125730","article-title":"Flavones as a Privileged Scaffold in Drug Discovery: Current Developments","volume":"16","author":"Pone","year":"2019","journal-title":"Curr. Org. Synth."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Pinto, C., Cidade, H., Pinto, M., and Tiritan, M.E. (2021). Chiral Flavonoids as Antitumor Agents. Pharmaceuticals, 14.","DOI":"10.3390\/ph14121267"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Pereira, A.M., Cidade, H., and Tiritan, M.E. (2023). Stereoselective Synthesis of Flavonoids: A Brief Overview. Molecules, 28.","DOI":"10.3390\/molecules28010426"},{"key":"ref_114","first-page":"31","article-title":"Putting benign by design into practice-novel concepts for green and sustainable pharmacy: Designing green drug derivatives by non-targeted synthesis and screening for biodegradability","volume":"2","author":"Leder","year":"2015","journal-title":"Sust. Chem. Pharm."},{"key":"ref_115","unstructured":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/1751-7915.12117","article-title":"Siderophores in environmental research: Roles and applications","volume":"7","author":"Ahmed","year":"2014","journal-title":"Microb. Biotechnol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/acs.jmedchem.2c01212","article-title":"Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections","volume":"66","author":"Almeida","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.2174\/0929867325666180706101404","article-title":"Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics","volume":"26","author":"Konreddy","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Gilbert-Girard, S., Savijoki, K., Yli-Kauhaluoma, J., and Fallarero, A. (2020). Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod. Microorganisms, 8.","DOI":"10.3390\/microorganisms8111834"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Zore, M., Gilbert-Girard, S., San-Martin-Galindo, P., Reigada, I., Hanski, L., Savijoki, K., Fallarero, A., Yli-Kauhaluoma, J., and Patel, J.Z. (2022). Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.926170"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"115921","DOI":"10.1016\/j.ejmech.2023.115921","article-title":"Design and synthesis of etrasimod derivatives as potent antibacterial agents against Gram-positive bacteria","volume":"263","author":"Zore","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.apsb.2023.01.013","article-title":"8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases","volume":"13","author":"Knez","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1038\/s41598-023-29929-7","article-title":"Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models","volume":"13","author":"Chamorro","year":"2023","journal-title":"Sci Rep."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Shafiei, M., Peyton, L., Hashemzadeh, M., and Foroumadi, A. (2020). History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. Bioorg. Chem., 104.","DOI":"10.1016\/j.bioorg.2020.104240"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"112082","DOI":"10.1016\/j.ejmech.2020.112082","article-title":"New azole antifungals with a fused triazinone scaffold","volume":"189","author":"Montoir","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/dta.2583","article-title":"The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs","volume":"11","author":"Banister","year":"2019","journal-title":"Drug Test. Anal."},{"key":"ref_127","first-page":"25","article-title":"Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances","volume":"2015","author":"Abdulrahim","year":"2016","journal-title":"Nov. Psychoact. Treat. UK Netw."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Gio\u00e9-Gallo, C., Ortigueira, S., Brea, J., Ra\u00efch, I., Azuaje, J., Paleo, M.R., Majellaro, M., Loza, M.I., Salas, C.O., and Garc\u00eda-Mera, X. (2023). Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs. Biomed. Pharmacother., 164.","DOI":"10.1016\/j.biopha.2023.114934"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"116121","DOI":"10.1016\/j.ejmech.2024.116121","article-title":"An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53","volume":"265","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: One protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/0008-5472.CAN-19-1036","article-title":"Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer","volume":"80","author":"Gu","year":"2020","journal-title":"Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Gomes, S., Bosco, B., Loureiro, J., Ramos, H., Raimundo, L., Soares, J., Nazareth, N., Barcherini, V., Domingues, L., and Oliveira, C. (2019). SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma. Cancers, 11.","DOI":"10.3390\/cancers11081151"},{"key":"ref_133","unstructured":"(2024, August 28). Why Do So Many Alzheimer\u2019s Clinical Trials Fail?. Available online: https:\/\/www.clinicalleader.com\/doc\/why-do-so-many-alzheimer-s-clinical-trials-fail-0001."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00018-015-1992-1","article-title":"MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer\u2019s disease","volume":"73","author":"Baranger","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/febs.14608","article-title":"Endoplasmic reticulum stress signalling\u2013from basic mechanisms to clinical applications","volume":"286","author":"Almanza","year":"2019","journal-title":"FEBS J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41467-018-05763-8","article-title":"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy","volume":"9","author":"Logue","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.trecan.2020.07.006","article-title":"Pharmacological Targeting of IRE1 in Cancer","volume":"6","author":"Pelizzari","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2020.08.028","article-title":"Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation\/chemotherapy in vivo","volume":"494","author":"Pineau","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"106687","DOI":"10.1016\/j.isci.2023.106687","article-title":"A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment","volume":"26","author":"Pelizzari","year":"2023","journal-title":"iScience"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"12761","DOI":"10.1021\/acs.jmedchem.1c00775","article-title":"Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_141","unstructured":"Moutayakine, A. (2023). Synthesis of Bioactive Nitrogen Heterocycles. [Ph.D. Thesis, Universidade de \u00c9vora]."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Marques, C.S., L\u00f3pez, \u00d3., Bagetta, D., Carreiro, E.P., Petralla, S., Bartolini, M., Hoffmann, M., Alcaro, S., Monti, B., and Bolognesi, M.L. (2020). N-1,2,3-Triazole-Isatin Derivatives for Cholinesterase and \u03b2-Amyloid Aggregation Inhibition: A Comprehensive Bioassay Study. Bioorg. Chem., 98.","DOI":"10.1016\/j.bioorg.2020.103753"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"102739","DOI":"10.1016\/j.bjid.2022.102739","article-title":"Protease inhibitors as a potential agent against visceral Leishmaniasis: A review to inspire future study","volume":"27","author":"Sreedharan","year":"2023","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"115471","DOI":"10.1016\/j.ejmech.2023.115471","article-title":"Molecular-level strategic goals and repressors in Leishmaniasis\u2014Integrated data to accelerate target-based heterocyclic scaffolds","volume":"257","author":"Abirami","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sousa, M.C., Varandas, R., Santos, R.C., Santos-Rosa, M., Alves, V., and Salvador, J.A.R. (2014). Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: Synergistic effects with miltefosine. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089939"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/14756366.2022.2150763","article-title":"Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: Synthesis, biological evaluation, and in silico studies","volume":"38","author":"Mohamed","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1002\/ajoc.202100684","article-title":"Ugi Adducts of Isatin as Promising Antiproliferative Agents with Druglike Properties","volume":"10","author":"Puerta","year":"2021","journal-title":"Asian J. Org. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Khetmalis, Y.M., Shivani, M., Murugesan, S., and Sekhar, K.V.G.C. (2021). Oxindole and its derivatives: A review on recent progress in biological activities. Biomed. Pharmacother., 141.","DOI":"10.1016\/j.biopha.2021.111842"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Kochetkov, K.A., Gorunova, O.N., and Bystrova, N.A. (2023). Biologically Oriented Hybrids of Indole and Hydantoin Derivatives. Molecules, 28.","DOI":"10.3390\/molecules28020602"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/acs.jmedchem.9b01138","article-title":"Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors","volume":"63","author":"Schauer","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Georges, A., Marcon, E., Greenblatt, J., and Frappier, L. (2018). Identification and Characterization of USP7 Targets in Cancer Cells. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-34197-x"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Oliveira, R.I., Guedes, R.A., and Salvador, J.A. (2022). Highlights in USP7 inhibitors for cancer treatment. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.1005727"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14728222.2023.2266571","article-title":"Ubiquitin-specific protease 7 (USP7): An emerging drug target for cancer treatment","volume":"27","author":"Carreira","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Saha, G., Roy, S., Basu, M., and Ghosh, M.K. (2023). USP7\u2013a crucial regulator of cancer hallmarks. Biochim. Biophys. Acta Rev. Cancer, 1878.","DOI":"10.1016\/j.bbcan.2023.188903"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Pereira, T., Abbasi, M., Oliveira, R.I., Guedes, R.A., Salvador, J.A., and Arrais, J.P. (2022). Deep generative model for therapeutic targets using transcriptomic disease-associated data\u2014USP7 case study. Brief. Bioinform., 23.","DOI":"10.1093\/bib\/bbac270"},{"key":"ref_156","unstructured":"(2023). Molecular Operating Environment (MOE), 2022.02, Chemical Computing Group ULC. H3A 2R7."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0944-7113(00)80065-3","article-title":"Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica","volume":"7","author":"Brinkhaus","year":"2000","journal-title":"Phytomedicine"},{"key":"ref_158","first-page":"372","article-title":"Madecassic acid inhibits the mouse colon cancer growth by inducing apoptosis and immunomodulation","volume":"19","author":"Zhang","year":"2014","journal-title":"J. BUON"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Valdeira, A.S.C., Ritt, D.A., Morrison, D.K., McMahon, J.B., Gustafson, K.R., and Salvador, J.A.R. (2018). Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling. Front. Chem., 6.","DOI":"10.3389\/fchem.2018.00434"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/znb-2017-0172","article-title":"Synthesis of madecassic acid derivatives and their cytotoxic activity","volume":"73","author":"Nhu","year":"2018","journal-title":"Zeitsch. Naturforsch. B"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.jnatprod.8b00864","article-title":"Madecassic Acid Derivatives as Potential Anticancer Agents: Synthesis and Cytotoxic Evaluation","volume":"82","author":"Valdeira","year":"2019","journal-title":"J. Nat. Prod."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.immuni.2014.12.010","article-title":"NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease","volume":"41","author":"Caruso","year":"2014","journal-title":"Immunity"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acs.jmedchem.3c00593","article-title":"Receptor Interacting Ser\/Thr-Protein Kinase 2 as a New Therapeutic Target","volume":"66","author":"Rivoal","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Pellegrini, E., Signor, L., Singh, S., Boeri Erba, E., and Cusack, S. (2017). Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177161"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.drudis.2013.11.002","article-title":"NF-kappabeta signaling and chronic inflammatory diseases: Exploring the potential of natural products to drive new therapeutic opportunities","volume":"19","author":"Killeen","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Sousa, C., Leit\u00e3o, A.J., Neves, B.M., Judas, F., Cavaleiro, C., and Mendes, A.F. (2020). Standardised comparison of limonene-derived monoterpenes identifies structural determinants of anti-inflammatory activity. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64032-1"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Mo\u00e7o, G., Sousa, C., Capit\u00e3o, A., MacKinnon, S.S., Leit\u00e3o, A.J., and Mendes, A.F. (2023). Synthesis of Carvone Derivatives and In Silico and In Vitro Screening of Anti-Inflammatory Activity in Murine Macrophages. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032263"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/C9OB02441G","article-title":"Isoquinolinequinone N-oxides as anticancer agents effective against drug resistant cell lines","volume":"18","author":"Kruschel","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1021\/acs.jmedchem.4c00705","article-title":"Discovery of Potent Isoquinolinequinone N-Oxides to Overcome Cancer Multidrug Resistance","volume":"67","author":"Kruschel","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Saraf, P., Tripathi, P.N., Tripathi, M.K., Tripathi, A., Verma, H., Waiker, D.K., Singh, R., and Shrivastava, S.K. (2022). Novel 5, 6-diphenyl-1, 2, 4-triazine-3-thiol derivatives as dual COX-2\/5-LOX inhibitors devoid of cardiotoxicity. Bioorg. Chem., 129.","DOI":"10.1016\/j.bioorg.2022.106147"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","article-title":"Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs","volume":"38","author":"Charlier","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1021\/acs.jmedchem.3c01825","article-title":"Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update","volume":"67","author":"Hillebrand","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Laufer, S. (2021). Covalent Kinase Inhibitors: An Overview. Protein Kinase Inhibitors, Springer.","DOI":"10.1007\/978-3-030-68180-7"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2533\/chimia.2022.435","article-title":"Never gonna give you up\u2013Current developments in covalent protein kinase inhibitors","volume":"76","author":"Hillebrand","year":"2022","journal-title":"Chimia"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1002\/anie.201707875","article-title":"The Cysteinome of Protein Kinases as a Target in Drug Development","volume":"57","author":"Chaikuad","year":"2018","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Drugs and Drug Candidates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2813-2998\/4\/1\/2\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:25:39Z","timestamp":1759919139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2813-2998\/4\/1\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ddc4010002"],"URL":"https:\/\/doi.org\/10.3390\/ddc4010002","relation":{},"ISSN":["2813-2998"],"issn-type":[{"type":"electronic","value":"2813-2998"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}